Related Experiment Video
Updated: Aug 29, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
A Cypher/ZASP mutation associated with dilated cardiomyopathy alters the binding affinity to protein kinase C
Takuro Arimura1, Takeharu Hayashi, Hajime Terada
1Department of Molecular Pathogenesis, Medical Research Institute, and Laboratory of Genome Diversity, School of Biomedical Science, Tokyo Medical and Dental University, Tokyo 101-0062, Japan.
Insights
Researchers identified a novel Cypher/ZASP gene mutation (D626N) linked to late-onset dilated cardiomyopathy in Japanese patients. This mutation alters protein interactions, suggesting a new mechanism for heart muscle disease.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Basis of Heart Disease
Background:
- Dilated cardiomyopathy involves ventricular dilation and systolic dysfunction.
- Genetic mutations in cytoskeletal proteins are known causes, but don't explain all cases.
- Cypher/ZASP, a Z-disc protein, is a candidate gene, supported by knockout mouse studies.
Purpose of the Study:
- To investigate sequence variations in the Cypher/ZASP gene in Japanese patients with dilated cardiomyopathy.
- To identify potential novel genetic causes of dilated cardiomyopathy.
Main Methods:
- Screened 96 unrelated Japanese dilated cardiomyopathy patients for Cypher/ZASP mutations.
- Conducted family studies to confirm mutation inheritance.
- Utilized yeast two-hybrid and pull-down assays to examine biochemical effects of the mutation.
Main Results:
- A novel D626N mutation in the Cypher/ZASP gene was found in a familial case, absent in controls.
- The mutation segregated with the disease in affected family members.
- Biochemical assays showed the D626N mutation increases Cypher/ZASP's affinity for protein kinase C.
Conclusions:
- The D626N Cypher/ZASP mutation is associated with late-onset dilated cardiomyopathy.
- This mutation may cause disease by altering protein kinase C binding.
- Identifies a novel pathogenic mechanism for dilated cardiomyopathy.
Abstract:
Dilated cardiomyopathy is characterized by ventricular dilation with systolic dysfunction of cardiac muscle. Recent genetic studies have revealed that mutations in genes for cytoskeleton proteins distributed in the Z-disc and/or intercalated discs of the cardiac muscle are major predictors of cardiomyopathy. However, as mutations in these genes can account for only a part of the patient population, there should be another disease-causing gene(s) for cardiomyopathy. Cypher/ZASP appears to be an ideal candidate for the cardiomyopathy causative gene, because Cypher/ZASP encodes a Z-disc associated protein, and recent studies have demonstrated that Cypher/ZASP knock-out mice develop cardiomyopathy. In this study, we searched for sequence variations in Cypher/ZASP in 96 unrelated Japanese patients with dilated cardiomyopathy. A D626N mutation located within the third LIM domain was identified in a familial case but not found in the unrelated controls. A family study of the patient showed that all affected siblings tested had the same mutation. Clinical information of the affected family members suggested that the mutation was associated with late onset cardiomyopathy. To reveal the biochemical changes due to the mutation, we performed a yeast two-hybrid assay and a pull-down assay. It was demonstrated by both assays that the D626N mutation of Cypher/ZASP increased the affinity of the LIM domain for protein kinase C, suggesting a novel biochemical mechanism of the pathogenesis of dilated cardiomyopathy.
More Related Videos
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Anaphase Promoting Complex
Mutations
Inhibition of Cdk Activity